Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: Relevance to Parkinson's disease pathogenesis

Journal of Neurochemistry

Volumn 110, Issue 3, 2009, Pages 1005-1013

  Chau, Kai Yin ^a   Ching, Hey Long ^a   Schapira, Anthony H V ^a   Cooper, J Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

synuclein; Parkinson's disease; Phosphorylation; Proteasomal inhibition

Indexed keywords

ALPHA SYNUCLEIN; CASEIN KINASE II; PHOSPHOPROTEIN; PROTEASOME; SERINE;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

ALPHA-SYNUCLEIN; CELL DEATH; CELL LINE, TUMOR; HUMANS; PARKINSON DISEASE; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; UP-REGULATION;

EID: 67650496503     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06191.x     Document Type: Article

References (29)

1. Anderson J. P., Walker D. E., Goldstein J. M. et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739 29752. (Pubitemid 44536983)
2. Bennett M. C. (2005) The role of alpha-synuclein in neurodegenerative diseases. Pharmacol. Ther. 105, 311 331.
3. Chen L. Feany M. B. (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8, 657 663. (Pubitemid 40594208)
4. Conway K. A., Rochet J. C., Bieganski R. M. Lansbury P. T. Jr. (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346 1349. (Pubitemid 33063102)
5. Cuervo A. M., Stefanis L., Fredenburg R., Lansbury P. T. Sulzer D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292 1295. (Pubitemid 39129234)
6. Elkon H., Melamed E. Offen D. (2004) Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J. Mol. Neurosci. 24, 387 400. (Pubitemid 41389376)
7. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M. S., Shen J., Takio K. Iwatsubo T. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160 164.
8. Gorbatyuk O. S., Li S., Sullivan L. F., Chen W., Kondrikova G., Manfredsson F. P., Mandel R. J. Muzyczka N. (2008) The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc. Natl Acad. Sci. USA 105, 763 768. (Pubitemid 351171782)
9. Inglis K. J., Chereau D., Brigham E. F. et al. (2009) Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J. Biol. Chem. 284, 2598 2602.
10. Korlipara L. V., Cooper J. M. Schapira A. H. (2004) Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells. Neuropharmacology 46, 562 569. (Pubitemid 38224442)
11. Kragh C. L., Lund L. B., Febbraro F., Hansen H. D., Gal W. P., El-Agnaf O., Richter-Landsberg C. Jensen P. H. (2009) Alpha synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J. Biol. Chem. 284, 10211 10222.
12. Larsen K. E., Schmitz Y., Troyer M. D. et al. (2006) Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915 11922. (Pubitemid 44772102)
13. Martinez-Vicente M., Talloczy Z., Kaushik S. et al. (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118, 777 788.
14. McNaught K. S. Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191 194. (Pubitemid 32011306)
15. Paleologou K. E., Schmid A. W., Rospigliosi C. C. et al. (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J. Biol. Chem. 283, 16895 16905.
16. Perez R. G., Waymire J. C., Lin E., Liu J. J., Guo F. Zigmond M. J. (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 22, 3090 3099. (Pubitemid 35379198)
17. Pronin A. N., Morris A. J., Surguchov A. Benovic J. L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275, 26515 26522. (Pubitemid 30676709)
18. Schapira A. H. (2006) Etiology of Parkinson's disease. Neurology 66 (10 Suppl. 4 S10.
19. Schapira A. H. (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97 109. (Pubitemid 350251942)
20. Shioi T., McMullen J. R., Kang P. M., Douglas P. S., Obata T., Franke T. F., Cantley L. C. Izumo S. (2002) Akt/Protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22, 2799 2809. (Pubitemid 34263000)
21. Smith W. W., Margolis R. L., Li X., Troncoso J. C., Lee M. K., Dawson V. L., Dawson T. M., Iwatsubo T. Ross C. A. (2005) Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 25, 5544 5552. (Pubitemid 40800646)
22. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839 840.
23. Sugeno N., Takeda A., Hasegawa T., Kobayashi M., Kikuchi A., Mori F., Wakabayashi K. Itoyama Y. (2008) Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death. J. Biol. Chem. 283, 23179 23188.
24. Tabrizi S. J., Orth M., Wilkinson J. M., Taanman J. W., Warner T. T., Cooper J. M. Schapira A. H. (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9, 2683 2689. (Pubitemid 30838169)
25. Takahashi M., Uchikado H., Caprotti D., Weidenheim K. M., Dickson D. W., Ksiezak-Reding H. Pasinetti G. M. (2006) Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 65, 1157 1169. (Pubitemid 44885940)
26. Takahashi M., Ko L. W., Kulathingal J., Jiang P., Sevlever D. Yen S. H. (2007) Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D. Eur. J. Neurosci. 26, 863 874. (Pubitemid 47274626)
27. Wakamatsu M., Ishii A., Ukai Y. et al. (2007) Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein. J. Neurosci. Res. 85, 1819 1825. (Pubitemid 46849629)
28. Waxman E. A. Giasson B. I. (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J. Neuropathol. Exp. Neurol. 67, 402 416. (Pubitemid 351653529)
29. Wersinger C. Sidhu A. (2005) Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry 44, 13612 13624. (Pubitemid 41443689)